media

Markets

Market Nav

News Details

03/05/2024 09:40

Bliss GVS Pharma posts Q4 net loss of Rs 11.46 cr

The company reported standalone net loss during the quarter stood at Rs 11.46 crore compared to net profit of Rs 6.11 crore in the previous year quarter.ÿ

Net revenue of the company rose moderately by 14.22 per cent at Rs 163.82 crore in January-March quarter of this fiscal as against Rs 143.42 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 4.65 per cent to Rs 138.67 crore from Rs 132.51 crore in year ago period.

Other Income grew by 30.56 per cent at Rs 8.46 crore versus (Mar'23 Rs 6.48 crore).

Operating Profit surged by 130.52 per cent to Rs 25.15 crore as against Rs 10.91 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 101.71 per cent in March quarter.

Interest declined by 69.22 per cent y-o-y to Rs 1.53 crore, while Taxation decreased by 261.11 per cent at Rs -3.77 crore (Mar'23 Rs 2.34 crore).